Rigel launches breast cancer drug Veppanu at $29,400 per month

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. EVMN
9. AAPL
10. DYN

Go back to Rigel launches breast cancer drug Veppanu at $29,400 per month
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Delayed: 47.35 -0.02 (0.04%)
Previous Close $47.37    52 Week High $4.38 
Open $46.85    52 Week Low $1.88 
Day High $47.88    P/E N/A 
Day Low $46.78    EPS $-1.12 
Volume 38,548